Log In
Print this Print this

Topical MGB-BP-3

  Manage Alerts
Collapse Summary General Information
Company MGB Biopharma Ltd.
DescriptionTopical formulation of an antibiotic that binds the minor groove of bacterial DNA
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationStaphylococcus
Indication DetailsTreat methicillin-resistant Staphylococcus aureus (MRSA) infection
Regulatory Designation U.S. - Qualified Infectious Disease Program (Treat methicillin-resistant Staphylococcus aureus (MRSA) infection)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today